ADAMTS13 and COVID-19: Therefore, prospective randomized clinical studies are needed to determine the relationship and causality between ADAMTS13 activity, complement, endothelial, and coagulation activation and to study the efficacy of treatments aiming at preventing and/or ameliorating COVID-19 microangiopathy.